Efficacy of immunotherapy to ragweed antigen tested by controlled antigen exposure

Annals of Allergy, Asthma and Immunology

Volumn 77, Issue 1, 1996, Pages 74-80

  Donovan, John Patrick ^a   Buckeridge, David Llewellyn ^a   Briscoe, Maureen Phyllis ^a   Clark, Reginald H ^a   Day, James Halliday ^a  

^a KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RAGWEED ANTIGEN;

ADULT; AGED; ALLERGY; ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; RAGWEED POLLEN; TREATMENT OUTCOME;

EID: 0029788985     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63483-7     Document Type: Article

References (29)

1. Bousquet J, Michel FB. Advances in specific immunotherapy. Clin Exp Allergy 1992;22:889-96.
2. Lower T, Henry J, Mandik L, et al. Compliance with allergen immunotherapy. Ann Allergy 1993;70:480-2.
3. Norman PS. Fatal misadventures. J Allergy Clin Immunol 1987;79:572-3.
4. Horak F. Seasonal allergic rhinitis: newer treatment approaches. Drugs 1993;45(4):518-27.
5. Kupa A. Allergic rhinitis and immunotherapy. Med J Aust 1992;157:9-11.
6. Juniper EF, Kline PA, Ramsdale BM, Hargreave FE. Comparison of the efficacy and side effects of aqueous steroid nasal spray (budesonide) and allergen-injection therapy (Pollinex-R) in the treatment of seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 1990;85:606-11.
7. Naclerio RM, Meier HL, Kagey-Sobotka A, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983;128: 597-602.
8. Creticos PS, Adkinson NF, Kagey-Sobotka A, et al. Nasal challenge with ragweed pollen in hay fever patients. J Clin Invest 1985;76:2247-53.
9. Morrow-Brown M, McIntyre D. Immunotherapy for grass pollenosis with Allpyral allergen extracts. Acta Allergol 1977;32:321-32.
10. Clarke PS. Improved diagnosis and treatment of allergic rhinitis by the use of nasal provocation tests. Ann Allergy 1988;60:57-60.
11. Clarke PS. Titration of immunotherapy by periodical nasal allergic challenges in the treatment allergic rhinitis. Med J Aust 1992;157:11-3.
12. Connell J. Quantitative intranasal pollen challenge. J Allergy 1968;41: 123-39.
13. Day JH, Clark R, Andersson B, et al. Mass provocation for entry into a study establishing efficacy and tolerability of Budesonide (Turbuhaler) in children with seasonal allergic rhinitis [Abstract]. J Allergy Clin Immunol 1991;87:152.
14. Day JH, Clark R, Briscoe MP, Dhillon M. Controlled pollen challenge is valuable in the assessment of anti-allergic medications [Abstract]. Clin Invest Med 1991;14(4):A5.
15. Day J, Briscoe M, Ploscowe V, Freeman G. Controlled pollen exposure for assessing efficacy of ophthalmic antihistamine/decongestant solutions for allergic conjunctivitis [Abstract]. Clin Invest Med 1992;15(4):A7.
16. Day J, Briscoe M, Buckeridge D, et al. Early onset of action of triamcinolone acetonide nasal spray as determined by a controlled antigen delivery in ragweed allergic subjects [Abstract]. J Allergy Clin Immunol 1994;93(1)part 2:164.
17. Day JH, Briscoe MP, Buckeridge D, et al. Onset of action and relative efficacy of single dose of terfenadine (TER) 60mg., cetirazine (CET) 10mg., loratadine (LOR) 10mg., or astemizole (AST) 10mg., for symptomatic relief of ragweed induced rhinitis using environmental exposure unit (EEU) 1995 [Abstract]. Ann Allergy, Asthma Immunol 1995;74(1):51.
18. Day JH, Buckeridge D, Briscoe M, et al. Onset of action and efficacy of astemizole (AST), cetirizine (CET), loratadine (LOR) and terfenadine (TER) as tested by controlled antigen challenge in an environmental exposure unit (EEU) [Abstract]. J Allergy Clin Immunol 1995;95(1):197.
19. Varney VA, Gaga M, Aber VR, et al. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. Br Med J 1991;302:265-9.
20. Moller C, Bjorksten B, Nilsson G, Dreborg S. The precision of the conjunctival provocation test. Allergy 1984;39:37-41.
21. Tuft L, Ettelson LN, Gupta K, Krueger C. Eye tests with inhalant allergens. J Allergy 1959;30:492-505.
22. Morrow Brown H. Some aspects of clinical allergy. Br J Clin Pract 1970; 24:513-21.
23. Immunotherapy subcommittee of the European Academy of Allergology and Clinical Immunology. Immunotherapy position paper. Allergy 1988; 43:(Suppl 60)1-33.
24. Subcommittee on skin tests of the European Academy of Allergology and Clinical Immunology. Skin tests used in type I allergy testing. Position paper. Allergy 1989;44:(Suppl 10)1-59.
25. Fei DTW, Lowe J, Jardieu P. A novel bioactivity assay for monoclonal antibodies directed against IgE. J Immunol Methods 1994;171:189-99.
26. Bousquet J, Maasch FB, Martinot B, et al. Double-blind, placebo-controlled immunotherapy with mixed grass pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol 1988;82:439-46.
27. Creticos PS. Immunology with allergens. JAMA 1992;268:2834-9.
28. Solomon WR. Volumetric studies of aeroallergen prevalence. I. Pollens of weedy forbs at a midwestern station. J Allergy Clin Immunol 1976;57: 318-27.
29. Solomon WR, Mathews KP. Aerobiology and inhalant allergens. In: Middleton E, Reed CE, Ellis EF, eds., vol. II, 2nd ed. Allergy principles and practice. Toronto: CV Mosby Co, 1983: 1143-202.